Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

CD271/p75NTR is a novel diagnostic marker, prognostic indicator and therapeutic target in SHH medulloblastoma

ABSTRACT: CD271/p75NTR is a novel diagnostic marker, prognostic indicator and therapeutic target in SHH medulloblastoma

PROVIDER: PRJNA421151 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR6348010.fastq.gz	Fastqsanger.gz
	SRR6348011.fastq.gz	Fastqsanger.gz
	SRR6348012.fastq.gz	Fastqsanger.gz
	SRR6348003.fastq.gz	Fastqsanger.gz
	SRR6348004.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 10

Similar Datasets

CD271/p75NTR is a novel diagnostic marker, prognostic indicator and therapeutic target in SHH medulloblastoma

Project description:The extensive heterogeneity both between and within the medulloblastoma (MB) subgroups underscores a critical need for variant-specific biomarkers and therapeutic strategies. We previously identified a role for the CD271/p75 neurotrophin receptor (p75NTR) in regulating stem/progenitor cells in the SHH MB subgroup. Here, we demonstrate the utility of CD271 as a novel diagnostic and prognostic marker for SHH MB using immunohistochemical analysis as well as transcriptome data across 763 primary tumors. Characterization of CD271+ and CD271- cells by RNA sequencing revealed that these two subpopulations are molecularly distinct, co-existing cellular subsets both in vitro and in vivo. MAPK/ERK signaling is upregulated in the CD271+ population and inhibiting this pathway reduced CD271 levels, stem/progenitor cell proliferation and cell survival as well as cell migration in vitro. Importantly, the MEK inhibitor selumetinib extends survival and reduces CD271 levels in vivo. Our study demonstrates the clinical utility of CD271 as both a diagnostic and prognostic tool for SHH MB tumors and reveals a novel role for MEK inhibitors in targeting CD271+ SHH MB cells.

2019-12-31 | GSE107701 | GEO

Indicator indicator

Project description:Indicator indicator

| PRJNA959903 | ENA

SHH medulloblastoma samples

Project description:Sequencing data of human SHH medulloblastoma samples

| EGAS00001000607 | EGA

RNA-seq analysis of adipose tissue-derived mesenchymal stem cells (AD-MSCs) selected for the surface marker CD271 (CD271+), compared to unsorted stromal vascular fraction (US), and the CD271- AD-MSCs population (CD271-).

Project description:Differences in gene expression between unsorted adipose tissue-derived mesenchymal stem cells (AD-MSCs), and a specific subpopulation that has been selected for the expression of the surface marker CD271. It is believed that the selection of this specific subpopulation from the heterogeneous SVF will lead to mesenchymal stem cells with higher angiogenetic potential.

2021-01-27 | E-MTAB-8740 | biostudies-arrayexpress

Olig2 targetome in SHH subgroup of medulloblastoma

Project description:Several basic helix-loop-helix (bHLH) transcription factors are upregulated in Sonic Hedgehog subgroup of medulloblastoma (SHH MB). Olig2, a neural bHLH transcription factor known to regulate differentiation of neural cell populations, is broadly expressed in mouse models of SHH MB. ChIP-Seq of Olig2 revealed its binding to a large number of sites near genes known to promote SHH MB tumorigenesis, suggesting a potential role for Olig2 in regulating transcriptional programme of MB.

2024-03-23 | GSE103824 | GEO

Developmental Basis of SHH Medulloblastoma Heterogeneity

Project description:Single-Nucleus RNA-Sequencing and Single-Cell RNA-Sequencing from SHH Medulloblastoma Tumors with MBEN histology

2023-11-21 | GSE214469 | GEO

Indicator exilis

Project description:Indicator exilis

| PRJNA959902 | ENA

Indicator willcocksi

Project description:Indicator willcocksi

| PRJNA959908 | ENA

Baeopogon indicator

Project description:Baeopogon indicator